← All trials
NCT06218628
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 5, 2024
- Primary completion
- Aug 22, 2029
- Completion date
- Aug 27, 2030
- First posted
- Jan 23, 2024
- Last posted
- May 3, 2024
- Enrollment
- 24
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Temple UniversityLead sponsor
- Temple UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.